2676 — Suzhou Novosense Microelectronics Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$15.82bn
- HK$14.35bn
- CNY1.96bn
- 27
- 15
- 49
- 16
Annual balance sheet for Suzhou Novosense Microelectronics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS/A | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 125 | 77.7 | 4,729 | 4,001 | 3,208 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 53.9 | 138 | 257 | 308 | 519 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 302 | 520 | 5,724 | 5,299 | 4,688 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 79.4 | 233 | 557 | 1,291 | 1,517 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 437 | 841 | 6,850 | 7,156 | 7,674 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 105 | 266 | 327 | 584 | 757 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 120 | 291 | 353 | 950 | 1,731 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 317 | 550 | 6,497 | 6,207 | 5,942 |
| Total Liabilities & Shareholders' Equity | 437 | 841 | 6,850 | 7,156 | 7,674 |
| Total Common Shares Outstanding |